BATON ROUGE, La. (BRPROUD) – Later this week Baton Rouge General (BRG) is opening a Specialty Infusion Center to administer monoclonal antibodies to COVID-19 patients. Only patients who fit the criteria will be eligible for the treatment.
BRG’s Bluebonnet campus has 15 infusion bays which will allow up to 80 infusions per day.
“Early data show that monoclonal antibodies can successfully reduce COVID-19 hospitalizations rates and emergency department visits,” said Dr. Louis Minsky, chief of staff at Baton Rouge General. “As our local hospitals are bursting at the seams with COVID-19 patients, many requiring critical care, the hope is to relieve some of that pressure.”
Staffing in the Center will be provided by the Louisiana Department of Health.
This treatment takes between 30-50 minutes with up to an hour of observation after.
BRG said a physician referral is required to receive the treatment. Eligibility includes testing positive for COVID-19, experiencing symptoms for 10 days or less and one of the following:
- 65 years old or older
- Have a BMI of more than 25 kg/m2, or if age 12-17, have BMI above the 85th percentile for their age and gender based on CDC growth charts
- Currently Pregnant
- Have a medical condition, including:
- Chronic kidney disease
- Cardiovascular disease (including congenital heart disease, hypertension)
- Down syndrome
- Liver disease
- Chronic lung disease
- Sickle cell disease
- Immunosuppressive disease or immunosuppressive treatment
- Current or former smoker
- History of stroke or cerebrovascular disease
- Current or history of substance abuse
- Neurodevelopmental disorders or other conditions that confer medical complexity
- Have a medical-related technological dependence (e.g., tracheostomy, gastrostomy)